Over the past twenty-five years, Kevin has dedicated his professional career to mastering the role of strategic, results-driven change agent who transforms complex organizations into streamlined, effective mission-driven operations generating measurable impact on important societal issues.  

Both as an independent consultant and in a wide variety of C-suite roles in both the non-profit and for-profit arena, Kevin has been an adroit manager of multi-million-dollar P&L, expert at cost containment, improving ROI, and ensuring fiscal responsibility and organizational compliance. In addition, Kevin has a proven track record as an innovative, principled fundraiser and cause marketer who has generated over $1 billion for cancer, HIV/AIDS, kidney disease, diabetes, reproductive rights, academia, and the arts and humanities. Kevin has led business operations, overseen business development and advancement, built supporting systems and infrastructures, managed intricate grant programs, event productions and logistics, and orchestrated successful turnarounds and project launches. 

Kevin is currently CEO and President of Alliance for Cancer Gene Therapy, which invests in innovative research and biotechnology to bring better, more permanent non-toxic therapies and cures to cancer patients. Prior to ACGT, Kevin was President and CEO of the Avon Breast Cancer Crusade and Executive Director of the Avon Foundation for Women. Kevin has been the founder and president of the following consulting firms: HGI Ventures, sold in 2003; Honeycutt Partners, Inc.; and CP Spencer Consulting LLC.